Object. Significant improvements in neurological function and pain relief are the benefits of aggressive surgical management of spinal metastatic disease. However, there is limited literature regarding the management of tumors with specific histological features. In this study, a series of patients undergoing spinal surgery for metastatic prostate cancer were reviewed to identify predictors of survival and functional outcome.
I n the US, prostate carcinoma is the most commonly diagnosed malignancy and the second most common cause of cancer-related death in men. 24 Although prostate cancer is generally considered responsive to hormone therapy in the form of androgen deprivation, up to 35% patients with prostate cancer may suffer from metastatic disease at the time of death. 34 The majority of these patients have bone metastases, and the spinal column is the most common osseous site. 4 When lesions arise in the spine, roughly one-third become symptomatic, causing neurological deficits, intractable pain, and/or mechanical instability, often requiring surgical treatment. 12, 20 Multiple studies have shown that the histopathological features of the primary cancer are strongly associated with prognosis in patients with metastatic spinal disease. 2, 3, 15, 16, 18, 20, 23, 38, 39 For example, patients with metastatic breast cancer often survive significantly longer than similar patients with metastatic spinal disease from lung cancer. 22, 33 As a result, aggressive surgical options have become increasingly important for managing metaSurgical management of prostate cancer metastatic to the spine static spinal disease. However, few studies in the literature on spinal metastases are pathological type-specific. Therefore, the purpose of this study was to review the outcomes of patients undergoing spinal surgery for metastatic prostate cancer. Particular attention was given to initial presentation, operative management, clinical and neurological outcomes, and factors associated with overall survival.
Methods

Patient Population and Selection Criteria
We reviewed the records of all patients who underwent surgical treatment at The University of Texas M. D. Anderson Cancer Center between 1993 and 2005 for prostate cancer that had metastasized to the spine. The study was reviewed and approved by the Institutional Review Board.
The selection criteria for undergoing surgical intervention for prostate spinal metastases required all patients to be deemed medically stable enough to tolerate the proposed surgery and to have at least 1 of the following symptoms: 1) obvious spinal deformity with intractable pain; 2) significant spinal cord compression; 3) prior irradiation of the site of progressive spinal involvement; or 4) medically intractable mechanical or neurological pain.
Data Collection
The prospectively compiled Brain and Spine Database was reviewed for demographic, clinical, radiographic, and pathological data on patients undergoing surgery for treatment of spinal metastatic disease from prostate cancer. Some of this data was identified retrospectively, however. Data collected regarding the primary prostate cancer included date of diagnosis, Gleason score, tumor stage, and treatment modalities, including resection, external-beam radiation and dosage, hormone treatment, and chemotherapeutic regimens. Data collected regarding the spinal metastases included the following: date of diagnosis; presenting signs and symptoms; motor function quantified by ASIA motor score; neurological function quantified by the Frankel grading system; type of pain (local, mechanical, or neurological [radicular/neurogenic claudication]); narcotic dose in morphine equivalents (mg/day); steroid dose in dexamethasone equivalents (mg/ day); continence; and ambulation status (using criteria described by Patchell et al. 26 ).
Neuroanatomy and Neuroimaging
The anatomical location of the spinal lesions was assessed using preoperative MR imaging. The levels of tumor involvement were categorized as follows: occipitocervical (occiput-C1); cervical (C2-6); cervicothoracic (C7-T1); thoracic (T2-11); thoracolumbar (T12-L1); lumbar (L2-4); lumbosacral (L5-S1); sacral (below S-1); thoracic/lumbar/sacral; cervical/thoracic/lumbar; and cervical/ thoracic/lumbar/sacral. The level of neurological compromise was categorized into occipitocervical, cervical, cervicothoracic, thoracic, thoracolumbar, lumbar, lumbosacral, and sacral. Lesions including occipitocervical, cervicothoracic, thoracolumbar, and lumbosacral were considered to be junctional. The location of the tumor within the spine was categorized as follows: anterior (from the anterior longitudinal ligament to the posterior longitudinal ligament), posterior (from the posterior longitudinal ligament to the spinous process), or both. Stability of the spinal segment was assessed using the Cybulski criteria. 8 The degree of spinal canal compression was estimated as follows: ≤ 25%, 26-50%, 51-75%, and > 75%.
Pathological Data
All patients treated had histologically verified prostate cancer confirmed at the M. D. Anderson Cancer Center.
Perioperative Data and Surgical Approach
Operative data included the type of surgical approach (which was dictated by location of disease within the spine at that level), presence and type of instrumentation, number of levels instrumented, estimated blood loss, and amount of blood transfused.
The anatomical location and extent of disease dictated the surgical approach, with the intention to remove as much tumor as possible and completely decompress the neural structures involved, using a paradigm reported by Fourney and Gokaslan. 10 An anterior or anterolateral approach was used if the disease was located predominantly in the vertebral body. A posterior or posterolateral approach was used when the disease was primarily posterior or posterolateral. A bipedicular approach was used for circumferential tumors or in regions of the spine that were difficult to access anteriorly. A combined anterior-posterior simultaneous approach was used if the disease involved the lateral elements of the spinal column with significant paraspinal extension. An anteroposterior staged approach was used for disease located at junctional zones with preexisting spinal deformity.
In patients with spinal instability, posterior arthrodesis was performed using allograft bone, and posterior stabilization was generally achieved with supporting instrumentation. The method of posterior stabilization varied depending on the anatomical location of the tumor. Lateral mass screws and plate or rod constructs were used in the cervical spine, and pedicle screw or pedicle hook constructs were generally used in the thoracic and lumbar spine. Extensive tumors involving both the anterior and posterior aspects of the spine were approached and stabilized either anteriorly and posteriorly or by a lone posterior transpedicular vertebrectomy technique, as previously described. 1 In the cervical and upper thoracic spine, anterior stabilization was achieved using the coaxial double-lumen methylmethacrylate technique (with anterior plating), as previously described. 21 Anterior stabilization of the mid-and lower thoracic and lumbar spine was achieved using methylmethacrylate or expandable titanium or stackable cages with an anterolateral plate.
All complications that occurred intraoperatively or within the first 30 days after the operation were considered early; those that occurred after 30 days were considered late. Complications were classified as major or minor according to the criteria of McDonnell et al. 19 The postoperative length of stay was recorded, and included time spent in the inpatient rehabilitation service.
Postoperative Data
Patients were clinically evaluated at time of discharge and at ~ 1, 3, 6, 12, 18, and 24 months postoperatively. Preoperative and postoperative Frankel grade, ASIA motor score, ambulatory status, continence, narcotic usage (morphine equivalents, mg/day), and steroid medication usage (dexamethasone equivalents, mg/day) were recorded. Follow-up spinal MR images were evaluated. Clinical or radiographic evidence of local or distant tumor recurrence in the spine was noted. Tumor growth at the operative site was considered local recurrence, and at any other spine site it was considered distant.
Statistical Methods
Chi-square and Fisher exact tests were used for categorical variables, and the Student t-test and Mann-Whitney test were used for continuous and ordinal variables. The Wilcoxon signed-rank test was used to compare paired outcomes. The Kaplan-Meier method was used to estimate postoperative survival. 17 Univariate and multivariate predictors of overall survival were performed using the Cox proportional hazards model. Variables significant at a probability value < 0.15 in the univariate analysis were tested through a backward stepwise selection process for their independent effect on overall survival. A probability value ≤ 0.05 was considered significant.
Results
Demographic Data and Clinical Characteristics
During the study period, 44 patients were identified who underwent a total of 47 surgical procedures for treatment of spinal metastatic disease from prostate cancer. As shown in Table 1 , the median age at diagnosis of primary prostate cancer was 62 years (range 46-84 years), at diagnosis of spinal metastasis it was 66 years (range 50-84 years), and at spinal surgery the median age was 68 years (range 51-85 years). The median time from diagnosis of spinal metastases to surgery was 19 months (range 0.1-90 months).
The histological classification of all prostate cancers was adenocarcinoma. The median Gleason score of patients in our study population was 8 (range 2-10), with the most common score being 9. The most common stage at diagnosis was Stage IV (27 patients, 61%). The median prostate-specific antigen value at time of diagnosis was 27.5 ng/ml (range 2.4-1520 ng/ml).
Treatment of the primary prostate cancer included 10 patients who underwent radical prostatectomy; 24 patients received external-beam radiation therapy, with a median dose of 70 Gy (range 30-74 Gy); and all patients received hormone treatment with either luteinizing hormone-releasing hormone agonists or orchiectomy. After failure of hormone treatment, the majority of patients underwent trials of various chemotherapeutic regimens. Nine patients underwent no chemotherapy, 13 received 1-3 different regimens, and 22 received > 3 different chemotherapeutic regimens. All tumors were hormone independent at time of surgery.
Preoperative Neuroimaging Characteristics
The sites of tumor within the spine and levels of neural compression are summarized in Table 2 . Each patient had only a single site of neural compression. The location of the metastases within the spine was distributed as follows: anterior only in 21 patients (48%); posterior only in 3 (7%); both anterior and posterior in 19 (43%); and intradural in 1 (2%). According to the Cybulski criteria of spinal instability in the setting of metastatic disease, spines in 27 patients (61%) were considered unstable. The severity of spinal canal compression was ≤ 25% in 16 patients, 26-50% in 12 patients, 51-75% in 13 patients, and 76-100% in 3 patients. Increased T2 signal intensity within the spinal cord was demonstrated in 15 (52%) of 29 patients with disease above L-2.
Preoperative Patient Characteristics
Preoperative patient characteristics, including symptoms, Frankel grades, narcotic use, and steroid use are summarized in Table 3 . Forty patients (91%) were taking narcotics and 28 (64%) were taking steroids. The median narcotic dose was 21.5 mg/day morphine equivalents (range 0.5-267 mg/day), and the median steroid dose was 16 mg/day dexamethasone equivalents (range 1.5-93.78 mg/day). Thirty-two patients (73%) were walking, and 33 (75%) were continent. One patient reported fecal incontinence, 3 noted urinary incontinence, and 7 complained of both. The median ASIA motor score was 92 (range 50-100). Twelve patients (27%) presented with acute neu- 
Surgical Procedure
Twenty-four patients (55%) had received prior radiation to the site of neural compression, with a median dose of 70 Gy (range 30-74 Gy). Six patients (14%) had previously undergone surgery for nontumor-related indications at the site of compression. Of the 47 procedures, a posterior-only approach was used in 19 cases (40%), an anterioronly approach was used in 14 cases (30%), a simultaneous anterior-posterior approach was used in 10 cases (21%), and an anterior and posterior staged procedure was used in 4 cases (9%).
Instrumentation was used in 31 patients (71%). Of the 31 procedures, anterior instrumentation alone was used in 10 (32%), posterior instrumentation alone was used in 14 (45%), and anterior and posterior instrumentation was used in 7 (23%). Of the 47 total procedures, polymethylmethacrylate was used in 12 cases (26%). The median estimated blood loss was 725 ml (range 0-6000 ml), and the median transfusion of packed red blood cells was 2 U (range 0-12 U). Eleven patients underwent postoperative radiation therapy, with a median dose of 30 Gy (range 30-36 Gy). Three patients required an additional procedure; 2 were distant from the original site of compression and 1 was at the same level of compression. One patient underwent an L-3 vertebrectomy with instrumentation in which polymethylmethacrylate and a plate were used. Two months postoperatively, he fell and subsequently developed pathological compression fractures at L-1 and L-2 associated with progressive deformity, which required surgical correction and stabilization. Another patient presented with compression at the occipitocervical junction, which was decompressed using a posterior approach. Subsequently (8 months later), he developed acute cord compression in the thoracic spine from metastatic disease. One patient presented with cervical disease that was decompressed via an anterior approach. Six months postoperatively, he developed radiculopathy at the same level and underwent decompression in which a posterior approach was used.
Postoperative Neurological Function
Frankel scores on discharge (p = 0.001), at 1 month (p < 0.001), at 3 months (p = 0.002), and at 6 months (p = 0.02) were significantly improved compared with preoperative scores. Postoperative Frankel grades at 1 month, stratified by preoperative grade, are shown in Table 4 , and Frankel grades assessed during the specified monthly intervals are shown in Table 5 . Of the patients who were nonambulatory preoperatively, 8 (67%) of 12 had regained their ability to ambulate at discharge. Of the 28 patients with fair to good motor function (Frankel D), 5 (18%) improved to Frankel E, 20 (71%) remained Frankel D, 1 (4%) worsened, and 2 (7%) died (see Table 6 ).
On discharge, 37 patients (84%) were continent, with 1 developing new fecal and urinary incontinence and 4 patients remaining at their baseline level of incontinence (1 with urinary, 1 with fecal, and 2 with both). Five patients had regained continence at discharge. At 1 month, 30 patients were continent and 3 were incontinent. At 3-month follow-up, 25 patients were continent and 1 was incontinent. At 6-month follow-up, 15 patients were continent and 2 were incontinent. At 1-year follow-up, 8 patients were continent and 1 was incontinent (which was his preoperative condition). The median postoperative ASIA motor score on discharge was 97 (range 60-100), a median improvement of 5 points. The median ASIA scores at the 1-month, 3-month, 6-month, and 1-year follow-up were 97 (range 64-100), 98 (range 66-100), 100 (range 84-100), and 96 (range 74-100), respectively.
Postoperative Medication Usage
The median postoperative narcotic dose was significantly lower than the preoperative dose at discharge (p < 0.001), 1 month (p < 0.001), and 3 months (p = 0.044). The median decrease in narcotic usage was 10 morphine equivalents (range -167 to +10) at 1 month, 2 (range -170 to +77) at 3 months, and 0.5 (range -170 to +44) at 1 year (see Fig. 1 ). The median postoperative steroid dose was significantly lower than the preoperative dose on discharge (p < 0.001), 1 month (p = 0.001), and 3 months (p = 0.008). However, there continued to be a reduction in the median steroid dose during the follow-up period despite the lack of a sufficient number of patients to achieve significance. The median decrease in steroid usage was 4 dexamethasone equivalents (range -24 to +40) at 1 month, 6 (range -24 to +8) at 3 months, and 2 (range −23 to +8) at 1 year (see Fig. 2 ).
Hospital Course and Complications
The median length of stay after surgery was 12 days (range 1-46 days). Complications occurred in 15 procedures (32%). There were 9 major complications (19%), and 6 were minor (13%). The 6 minor complications included 3 durotomies closed intraoperatively, a postoperative ileus requiring nasogastric tube placement, a postthoracotomy radiculopathy, and a superficial wound infection treated with antibiotics. The 9 major complications included a debridement and reclosure for a chronic deep wound infection; deep venous thrombosis; a postoperative CSF leak requiring subsequent surgical closure; a fatal intraoperative arrhythmia; a case of prolonged postoperative dysphagia in a cervical case requiring percutaneous endoscopic gastrostomy tube placement for feeding; a fatal case of gastrointestinal and genitourinary hemorrhages; a postoperative pneumonia; a fatal postoperative myocardial infarction in a patient who had experienced the infarction within 6 months of surgery but had acutely developed neurological deficits during radiation treatment; and a retroperitoneal hematoma requiring surgical evacuation, with subsequent fungal sepsis and death. Thirteen complications were early (28%), and 2 were late (4%), including a chronic wound infection requiring operative debridement and closure, and a persistent postthoracotomy radiculopathy. There were 4 deaths within 30 days of operation. We performed multivariate logistical regression for predictors of complications, and found that age ≥ 65 years at the time of surgery was a significant factor (p = 0.005).
Predictors of Survival
The median survival estimated by Kaplan-Meier analysis was 5.4 months (95% CI 0.8-10.1). We identified several predictors of survival by multivariate analysis, including Gleason score < 8 (p = 0.002), total number of metastases ≤ 5 (p = 0.001), absence of lymph node metastases at time of spinal surgery (p = 0.04), and degree of compression of the spinal canal ≤ 25% (p = 0.001).
Discussion
The incidence of prostate cancer has continued to rise throughout the world, and it is estimated that there will be ~ 900,000 new cases worldwide per year by 2010. 24 Given that > 90% of prostate cancers refractory to hormone therapy metastasize to bone, with the spine being the most common osseous site, it is likely that the incidence of spinal metastases will also increase in such patients in years to come. 4, 34 Unfortunately, although such spinal lesions are often clinically silent, many cause significant pain and neurological dysfunction that significantly affect quality of life. 12, 20 The management option chosen in patients with metastatic spinal disease is dependent on the histological classification of the primary cancer, because this has significant implications for treatment and prognosis. 2, 3, 15, 16, 18, 20, 23, 38, 39 However, few series in the literature deal specifically with management of spinal metastases from specific cancers. 5 In our study, we sought to characterize the clinical presentation, surgical management, and outcomes in a large series of patients undergoing spinal surgery for symptomatic prostate cancer metastases to identify patient characteristics that may contribute to better survival and functional outcome. Here we show that surgery provides a durable functional benefit. We also identify several factors that predict better survival in patients undergoing surgery.
The ideal management of prostate cancer metastasis involves a multidisciplinary approach including hormone therapy, chemotherapy, radiotherapy, and surgery. 3, 30 Prostate cancer responds to hormone therapy in the form of androgen deprivation, and more recently, chemotherapy consisting of docetaxel has been found to provide a modest survival benefit. 27, 37 Medical management of symptomatic spinal disease involves the use of corticosteroids, analgesics, and bisphosphonates, the latter of which not only treat the skeletal lesions but also reduce pain and fracture risk associated with androgen deprivation-induced osteoporosis.
14 Although still considered a relatively new radiation treatment option for spinal metastases, stereotactic radiosurgery may offer advantages over conventional radiation therapy for prostate cancer metastases. 9, 11 Surgical treatment of prostate cancer metastatic to the spine is considered palliative. Nonetheless, health-related quality of life may be significantly improved when surgical decompression and spinal stabilization are conducted in combination with radiation therapy, as shown by Patchell et al. 26 in a prospective randomized trial evaluating surgical treatment of patients with metastatic epidural spinal cord compression from various tumor histological types. Although spinal metastases from prostate cancer are often radiosensitive, surgical intervention in selected patients may be of benefit. At our institution, an operation is considered for patients in whom it is medically safe to perform surgery and who have a life expectancy of at least 3 months, if they have the following symptoms: progressive neurological deficits due to neural compression, mechanical instability, progressive deformity, inadequate response to radiation therapy, and/or medically intractable pain. The technical feasibility of surgery is also an important consideration. All patients in our series had a single site of neural compression, similar to the patient population reported by Patchell et al. Thus, our results cannot be generalized to all patients with prostate cancer who have metastatic disease to the spine and who may have multiple sites of neural compression.
There are only 2 published series regarding the treatment of spinal metastases from prostate cancer. 5, 32 The study by Shoskes and Perrin 32 included 28 patients treated surgically for spinal cord compression from metastatic prostate cancer. Motor deficit and back pain were the most common presenting symptoms in this series. The thoracic spine was the most common site of cord compression. Almost one-half of their study population was nonambulatory. Motor improvement was seen in the majority of these patients; however, palliation of pain was not reported. The median survival was 9.5 months. In a more recent study by Cereceda et al. 5 reporting the multimodality management of the disease in 119 patients with prostate cancer, 14 patients underwent 15 procedures for spinal cord compression. Again, back pain and motor deficit were the most common symptoms. One-third of their patients were nonambulatory preoperatively. Onehalf of the patients received preoperative external-beam radiation therapy to the site of compression. The thoracic spine was the most common site of compression. Pain improvement and improved motor functioning was observed in most patients; however, this improvement was not quantified. The median survival of these patients was 4 months, and the mean survival was 12.5 months. The limitations of these studies include small patient populations and limited indications for surgical interventions, whereas our study includes all indications for surgical intervention and a larger sample size.
In our series, the median survival following surgery was > 5 months. Given this life expectancy in the setting of metastatic disease, selected patients diagnosed with prostate cancer metastatic to the spine may benefit from aggressive surgical intervention. Surgery may improve performance status and permit successful administration of additional effective systemic treatments (for example, hormone ablation therapy and chemotherapy) that play a role in palliation and improved clinical outcome. Consideration for surgery is further supported by the large proportion of patients who maintained or improved their neurological function (based on Frankel, ASIA, ambulation, and continence status) and pain level (based on opioid usage status). This was not a prospectively controlled study, and other factors such as type and extent of adjuvant therapy may play a role in improving clinical outcome following surgery. However, our results corroborate those provided from other series. 6, 7, 13, 23, 26, 31, 35, 36, 40 Reasons for such improvements are unknown; however, it is likely that direct surgical decompression and stabilization allow for improvement in neurological function and ambulation by alleviating neural compression and by addressing mechanical pain associated with tumor-induced instability.
Postoperative Complications
Although it appears that improvements in health-related quality of life may occur following such procedures, this potential must be balanced against surgery-related morbidity and the prognosis for survival in each individual patient. A review of multiple series involving surgical management of metastatic spinal disease shows complication rates ranging from 10 to 52%. 3, 25, 31 In our study, complications occurred in 32% of procedures, but in only 19% were the complications considered major based on the classification of McDonnell et al. 19 Advanced age at the time of surgery (≥ 65 years) was found to be an independent factor associated with complications. Interestingly, in this series the likelihood of complications was not associated with use of steroids preoperatively, acute neurological deterioration, presence of myelopathy, blood transfusion, previous radiation to the surgical area, or lung metastases at the time of spinal surgery.
Prognostic Factors
Scoring systems have been proposed to determine which patients with spinal metastases benefit most from surgery. 38, 39 In such systems the importance of histological type or grade of primary tumor in determining prognosis is recognized, but the absolute value of such a risk association is arbitrarily assigned. Moreover, given that close to 10 different tumor types are grouped together in these systems, the generalization of such results to the patient with prostate cancer may not be accurate. In an effort to analyze factors associated with survival following surgery, thus allowing us potentially to identify patients at high likelihood of benefiting from surgery in the future, we looked at various patient characteristics via a multivariate regression model. Not surprisingly, metastatic burden was found to be an independent factor associated with worse survival. Specifically, an increasing number of metastases and the presence of lymph node metastasis were associated with shorter survival, although the significance of lymph node involvement in prostate cancer is unknown. Extent of systemic disease has previously been reported to affect survival following surgery for spinal metastasis in other studies of lesions with varied histological findings. 38, 39 Likewise, higher initial Gleason scores have been shown to be predictive of the probability and time to the development of metastatic disease in patients with prostate cancer as the primary disease. 28, 29 We found that a lesser degree of spinal canal compression was also associated with increased survival. One possible explanation is that greater spinal canal compression is a marker of extensive or rapidly progressive local disease, and is therefore associated with more aggressive or advanced systemic disease. Another possible explanation is that greater spinal canal compression, regardless of tumor behavior, is associated with more severe or longstanding pain and neurological dysfunction, both of which may indirectly affect survival in the debilitated patient. This latter potential explanation is supported by Sioutos et al., 33 who found that preoperative neurological status, specifically the ability to ambulate, was an independent predictor of improved survival in patients with thoracic spinal metastases and cord compression.
Despite the identification of important factors associated with clinical outcomes, this study is subject to the weaknesses inherent to retrospective studies. The type of surgery and the characteristics of medical therapy were neither controlled nor randomized; treatments were performed according to the preferences of the surgical and oncology teams. Because of the relatively small number of patients, this study may be underpowered to identify other factors associated with complications or survival that have been previously published on spinal metastatic surgery. The small number of patients is not surprising for this histological type, however, because patients with prostate cancer tend to be older and may be poor surgical candidates; they may have multiple metastases, which may be better treated with systemic therapies; and prostate cancer tends to be relatively radiosensitive and amenable to radiotherapy. Larger prospective controlled or multicenter studies would be helpful to confirm our observations.
Conclusions
Our results suggest that direct decompressive spinal surgery with spinal reconstruction may improve or preserve neurological function and reduce narcotic and steroid medication requirements in patients with prostate cancer metastatic to the spine. In considering surgery, however, patients should be evaluated individually, with special attention given to overall medical condition and prognosis. Specifically, age, metastatic burden, initial Gleason score, and extent of spinal canal compression on preoperative imaging may help with risk stratification for such surgical candidates.
